Celularity Inc — Director's Dealing 2023

Mar 28, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celularity Inc (CELU)
CIK: 0001752828
Period of Report: 2023-03-27

Reporting Person: Hariri Robert J (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-03-27	Class A Common Stock	A	2084854	$0.8343	Acquired	10159850	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-03-27	Warrants (Right to Buy)	$3.00	A	2084854	Disposed	2028-03-27	Class A Common Stock (2084854)	Direct

Footnotes

F1: On March 27, 2023, the Reporting Person purchased directly from the Issuer (i) 2,084,854 shares of the Issuer's Class A common stock at a price of $0.8343 per share, and (ii) a 5-year immediately exercisable warrant to purchase 2,084,854 shares of the Issuer's Class A common stock at an exercise price of $3.00, at a price of $0.125 per whole share underlying the warrant, or an aggregate purchase price of $2.0 million pursuant to a securities purchase agreement dated March 20, 2023.

F2: This includes 131,234 shares underlying restricted stock units subject to vesting.